Picture of Verastem logo

VSTM — Verastem News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Verastem Inc expected to post a loss of $1.03 a share - Earnings Preview

* Verastem Inc  VSTM.OQ   VSTM.O  is expected to show no
change in
quarterly revenue when it reports  results on May 7 (estimated)
for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Verastem Inc is for a
loss of
$1.03 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Verastem
Inc is
$32.00​, above​ its last closing price of $10.36. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.74       -0.62      -1.02     Missed  -64.5
 Sep. 30 2023  -0.87       -0.84      -0.75     Beat    11
 Jun. 30 2023  -1.07       -1.06      -1.37     Missed  -29.2​
 Mar. 31 2023  -0.96       -0.98      -0.96     Beat    2.4
 ​​Dec.        -1.20       -1.18      -0.96     Beat    18.4
 31 2022                                                
 Sep. 30 2022  -1.46       -1.46      -1.08     Beat    26​
 Jun. 30 2022  -1.32       -1.32      -1.44     Missed  -9.1
 Mar. 31 2022  -0.97       -0.98      -1.08     Missed  -9.8
 This summary was machine generated May 3 at 12:13 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Verastem

See all news